Intrinsic value of Telix Pharmaceuticals Limited (TLX)
Live fair value data for Telix Pharmaceuticals Limited (TLX) is currently unavailable. Please check again shortly.
Current Price: $48.00
Valuation: Undervalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Telix Pharmaceuticals Limited (TLX) undervalued or overvalued?
Based on the current model output, Telix Pharmaceuticals Limited appears to be undervalued with a upside of 21.00%.
Fair value vs market price — Telix Pharmaceuticals Limited (TLX)
Unlock premium access to view the live fair value comparison against current market price for TLX.
Frequently Asked Questions - TLX
How is TLX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TLX.
Is TLX undervalued or overvalued right now?
TLX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TLX: open their intrinsic value pages.